Home » Biotechnology » Tuberculosis Diagnostics Market

Tuberculosis Diagnostics Market By Test Type (Radiographic Methods, Laboratory Methods, Nucleic Acid Testing, Phage Assay, Cytokine Detection Test, Detection Of Drug Resistance, Mantoux Test) – Growth, Future Prospects, And Competitive Analysis, 2017 -2025

Summary
Table Of Content

Market Insights

This report on the global tuberculosis diagnostics market studies various tuberculosis diagnostic test types. WHO and the Centers for Disease Control and Prevention (CDC) are leading efforts to raise global awareness of tuberculosis and improve diagnostic methods. The large patient pool suffering from tuberculosis, rising public awareness regarding tuberculosis and early diagnosis, and technological advancement in the testing methods, such as the Mantoux test and the cytokine detection test, are the driving factors for the tuberculosis diagnostics market.

For the purpose of this study, the various types of tuberculosis diagnostic tests studied include radiography methods, laboratory methods, nucleic acid testing, phage assays, cytokine detection tests, detection of drug resistance, and the Mantoux test. Market size estimates and forecasts for these segments are provided in US$ Mn, along with the respective CAGRs for the period 2017-2025, using 2016 as the base year.The global tuberculosis diagnostics market is segmented geographically into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa markets. Market size estimates and forecasts for these segments are provided in US$ Mn, along with the respective CAGRs for the period 2017-2025, using 2016 as the base year.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints, and opportunities) to have a good understanding of the current and anticipated trends in the global tuberculosis diagnostics market. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with a profile of key market players currently enjoying prominent positions in the global tuberculosis diagnostics market. The key players profiled in this report are Abbott Laboratories, Alere Inc., Becton Dickinson and Company, bioMérieux SA, Cepheid Inc., Epistem plc, F. Hoffmann-La Roche Ltd., Hain Lifescience GmbH, Hologic Corporation, Thermo Fisher Scientific, Inc., and Qiagen.

Based on test type, the global tuberculosis diagnostics market is categorized into:

Radiographic Methods
Laboratory Methods
Smear Microscopy
culture-based test
Nucleic acid testing
Phage Assay
Cytokine Detection Test
Detection of Drug Resistance
Mantoux Test

Tuberculosis is one of the leading causes of death worldwide. According to the World Health Organization, in 2013, around 9 million new cases of tuberculosis were reported, with approximately 1.5 million deaths. The tuberculosis diagnostic market segment is driven by factors such as the increasing diagnosis rate in the high prevalence regions, advanced technologies such as radiographic methods and cytokine detection tests, the demand for cost-efficient diagnostic tests, and the launching of technologically advanced diagnostic kits. In 2016, laboratory diagnostics held the largest market share in the test type segment, primarily due to factors such as the rising prevalence of tuberculosis and the fact that they are affordable and very easy to perform.

The limitations of laboratory diagnostic tests, as well as the lengthy incubation period required for diagnosis interpretation, reduce their accuracy. Nucleic acid testing and Mantoux testing will be the fastest growing markets throughout the forecast period of 2017–2025 due to key market drivers such as advanced techniques, a shorter incubation period required for the interpretation of the diagnosis performed, and high accuracy. The major players involved in the manufacturing of the diagnostic kits and equipment are Alere, Inc., Abbott Laboratories, Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, F. Hoffmann-La Roche AG, Qiagen, BioMerieux SA, Cephied, Inc., Epistem plc., Hain Lifescience GmbH, and Hologic Corporation.

For the purpose of this study, the global tuberculosis diagnostics market is categorized into three segments:

North America
- US.
- Canada
Europe
- Germany
- France
- UK.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of the Middle East and Africa

North America will be the fastest-growing market for tuberculosis diagnostics throughout the forecast period of 2017–2025. According to the Centers for Disease Control and Prevention, approximately 9,557 new cases of TB were reported in 2015; the market growth is mainly attributed to rising public awareness of tuberculosis leading to early diagnosis, an evolved reimbursement scenario, and developed healthcare infrastructure. According to the World Health Organization (WHO), in 2015, 323,000 new TB cases were reported in Europe, i.e., approximately 900 people suffered from TB each day. Europe is expected to be the second-largest market due to the rising prevalence of MDR-TB, government and non-government organization grants to strengthen R&D facilities to launch novel tuberculosis diagnostic testing kits and supportive regulatory approval for the tuberculosis diagnostics market.

In the base year 2016, Asia Pacific was observed as the leading market for tuberculosis diagnostics due to factors such as the rising prevalence of tuberculosis (according to the World Health Organization, in South East Asia, annually 2 million people are diagnosed with TB), a competitive market due to manufacturers involved in tuberculosis diagnostic kit production, increasing disposable income in these regions, and government and non-government initiatives to mitigate tuberculosis as per TB programs. However, factors such as developing health infrastructure and increasing awareness about tuberculosis diagnostics are going to fuel the rapid growth of the tuberculosis diagnostics market in Latin America, the Middle East, and Africa in the near future.

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Tuberculosis Diagnostics Market Portraiture
2.2 Global Tuberculosis Diagnostics Market, by Test Type 2016 Vs 2025 (US$ Mn)
2.3 Global Tuberculosis Diagnostics Market, by Geography, 2016 (Value %)

Chapter 3 Global Tuberculosis Diagnostics Market: Market Dynamics and Future Outlook
3.1 Overview
3.2 Market Drivers
3.2.1 Rising prevalence of Tuberculosis
3.2.2 For a full, detailed list, browse our report
3.3 Market Restraints
3.3.1 Costly diagnosis and lack of skilled labor to perform accurate diagnosis will hinder the growth of tuberculosis diagnostic market
3.3.2 For a full, detailed list, browse our report
3.4 Market Opportunities
3.4.1 Increasing number of patients reported with MDR-TB and hospital acquired infection
3.4.2 For a full, detailed list, browse our report
3.5 Attractive Investment Proposition
3.6 Market Competition Assessment: Global Tuberculosis Diagnostics Market, by Key Players

Chapter 4 Global Tuberculosis Diagnostics Market, by Test Type, 2015-2025 (US$ Mn)
4.1 Introduction
4.2 Radiographic Methods
4.3 Laboratory Methods
4.3.1 Smear Microscopy
4.3.2 Culture Based Test
4.4 Nucleic Acid Testing
4.5 Phage Assay
4.6 Cytokine Detection Test
4.7 Detection of Drug Resistance
4.8 Mantoux Test

Chapter 5 Global Tuberculosis Diagnostics Market, by Geography, 2015-2025 (US$ Mn)
5.1 Preface
5.2 North America
5.2.1 North America Tuberculosis Diagnostics Market,by Test Type, 2015-2025 (US$ Mn)
5.2.2 North America Tuberculosis Diagnostics Market,by Country, 2015-2025 (US$ Mn)
5.2.2.1 U.S.
5.2.2.2 Canada
5.3 Europe
5.3.1 Europe Tuberculosis Diagnostics Market,by Test Type, 2015-2025 (US$ Mn)
5.3.2 Europe Tuberculosis Diagnostics Market,by Country, 2015-2025 (US$ Mn)
5.3.2.1 U.K.
5.3.2.2 Germany
5.3.2.3 Rest of Europe
5.4 Asia Pacific
5.4.1 Asia Pacific Tuberculosis Diagnostics Market, by Test Type, 2015-2025 (US$ Mn)
5.4.2 Asia Pacific Tuberculosis Diagnostics Market,by Country, 2015-2025 (US$ Mn)
5.4.2.1 China
5.4.2.2 Japan
5.4.2.3 Rest of Asia Pacific
5.5 Latin America
5.5.1 Latin America Tuberculosis Diagnostics Market,by Test Type, 2015-2025 (US$ Mn)
5.5.2 Latin America Tuberculosis Diagnostics Market,by Country, 2015-2025 (US$ Mn)
5.5.2.1 Brazil
5.5.2.2 Mexico
5.5.2.3 Rest of Latin America
5.6 Middle East and Africa
5.6.1 Middle East and Africa Tuberculosis Diagnostics Market,by Test Type, 2015-2025 (US$ Mn)
5.6.2 Middle East and Africa Tuberculosis Diagnostics Market,by Country, 2015-2025 (US$ Mn)
5.6.2.1 GCC
5.6.2.2 Rest of Middle East and Africa

Chapter 6 Company Profiles
6.1 Abbott Laboratories
6.2 Alere, Inc.
6.3 Becton Dickinson and Company
6.4 bioMérieux SA
6.5 Cepheid Inc.
6.6 Epistem plc
6.7 F. Hoffman La Roche AG
6.8 Hain Lifescience GmbH
6.9 Hologic Corporation
6.10 Thermo Fisher Scientific, Inc.
6.11 QIAGEN

List of Figures

FIG. 1 Global Tuberculosis Diagnostics Market: Research Methodology
FIG. 2 Global Tuberculosis Diagnostics Market, by Test Type, 2016 (US$ Mn)
FIG. 3 Global Tuberculosis Diagnostics Market Share, by Geography, 2016 (Value %)
FIG. 4 Attractive Investment Proposition, by Geography, 2016
FIG. 5 Market Positioning of Key Tuberculosis Diagnostics Vendors, 2016
FIG. 6 Radiographic Methods Market, 2015 – 2025 (US$ Mn)
FIG. 7 Laboratory Methods Market, 2015 – 2025 (US$ Mn)
FIG. 8 Nucleic Acid Testing Market, 2015 – 2025 (US$ Mn)
FIG. 9 Phage Assay Market, 2015 – 2025 (US$ Mn)
FIG. 10 Cytokine Detection Test Market, 2015 – 2025 (US$ Mn)
FIG. 11 Detection of Drug Resistance Market, 2015 – 2025 (US$ Mn)
FIG. 12 Mantoux Test Market, 2015 – 2025 (US$ Mn)
FIG. 13 U.S. Tuberculosis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 14 Canada Tuberculosis Diagnostics Market, 2015– 2025 (US$ Mn)
FIG. 15 U.K. Tuberculosis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 16 Germany Tuberculosis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 17 Rest of Europe Tuberculosis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 18 China Tuberculosis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 19 Japan Tuberculosis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 20 Rest of Asia Pacific Tuberculosis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 21 Brazil Tuberculosis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 22 Mexico Tuberculosis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 23 Rest of Latin America Tuberculosis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 24 GCC Tuberculosis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 25 Rest of Middle East and Africa Tuberculosis Diagnostics Market, 2015 – 2025 (US$ Mn)

List of Tables

TABLE 1 Global Tuberculosis Diagnostics Market, By Test Type, 2015-2025 (US$ Mn)
TABLE 2 Global Tuberculosis Diagnostics Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 3 North America Tuberculosis Diagnostics Market, by Test Type, 2015 – 2025 (US$ Mn)
TABLE 4 North America Tuberculosis Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 5 Europe Tuberculosis Diagnostics Market, by Test Type, 2015 – 2025 (US$ Mn)
TABLE 6 Europe Tuberculosis Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 7 Asia Pacific Tuberculosis Diagnostics Market, by Test Type, 2015 – 2025 (US$ Mn)
TABLE 8 Asia Pacific Tuberculosis Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 9 Latin America Tuberculosis Diagnostics Market, by Test Type, 2015 – 2025 (US$ Mn)
TABLE 10 Latin America Tuberculosis Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 11 Middle East and Africa Tuberculosis Diagnostics Market, by Test Type, 2015 – 2025 (US$ Mn)
TABLE 12 Middle East and Africa Tuberculosis Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 13 Abbott Laboratories: Company Snapshot (Business Description, Financial Information, Product Portfolio and News Coverage)
TABLE 14 Alere, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio and News Coverage)
TABLE 15 Becton Dickinson and Company: Company Snapshot (Business Description, Financial Information, Product Portfolio and News Coverage)
TABLE 16 bioMérieux SA.: Company Snapshot (Business Description, Financial Information, Product Portfolio and News Coverage)
TABLE 17 Cepheid Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio and News Coverage)
TABLE 18 Epistem plc: Company Snapshot (Business Description, Financial Information, Product Portfolio and News Coverage)
TABLE 19 F. Hoffman La Roche AG: Company Snapshot (Business Description, Financial Information, Product Portfolio and News Coverage)
TABLE 20 Hain Lifescience GmbH: Company Snapshot (Business Description, Financial Information, Product Portfolio and News Coverage)
TABLE 21 Hologic Corporation: Company Snapshot (Business Description, Financial Information, Product Portfolio and News Coverage)
TABLE 22 Thermo Fisher Scientific Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio and News Coverage)
TABLE 23 QIAGEN: Company Snapshot (Business Description, Financial Information, Product Portfolio and News Coverage)

Frequently Asked Questions:

What is the size of Tuberculosis Diagnostics Market?

The market for Tuberculosis Diagnostics Market is expected to reach US$ 3,326.9 Mn By 2025.

What is the Tuberculosis Diagnostics Market CAGR?

The Tuberculosis Diagnostics Market is expected to see significant CAGR growth over the coming years, at 4.5%.

What is the Forecast period considered for Tuberculosis Diagnostics Market?

The report is forecasted from 2015-2025.

What is the base year considered for Tuberculosis Diagnostics Market?

The base year of this report is 2014.

Who are the major players in this market?

Abbott Laboratories, Alere Inc., Becton Dickinson and Company, bioMérieux SA, Cepheid Inc., Epistem plc, F. Hoffmann-La Roche Ltd., Hain Lifescience GmbH, Hologic Corporation, Thermo Fisher Scientific, Inc. are some of the major players in the global market.

Purchase Options

Single User

$3699

Multi User

$4699

Custom Report

$6699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –